Industrial software maker PTC forecast first-quarter revenue below estimates on Wednesday, signaling continued weakness in ...

The functionality is only available via the PTC for testing and may not become a full-fledged feature, pending user feedback.

PTC Therapeutic's Upstaza gene therapy for patients with genetic disorder AADC deficiency has been recommended for approval in the EU, setting up another test of the commercial prospects for ...

“We believe that the combination of Codebeamer and Pure::Variants positions PTC as one of the leading providers of software requirements, configuration, testing, and validation solutions in the ...

The company is banking on revenue from its Sanofi deal and vaccines in development, including an experimental COVID-flu ...

While the exact cause of PTC remains elusive, certain risk factors ... fine-needle aspiration biopsy, and molecular testing, in the best thyroid cancer hospital in India to confirm the presence of ...

This is the first gene therapy for AADC deficiency to receive US regulatory approval and the first that can be administered directly to the brain.

[email protected] Cytological fine-needle aspiration diagnosis of thyroid nodules can be improved by testing for BRAF, RET/PTC and other mutations. BRAF is a reliable diagnostic marker for ...

Renesas announced the world's first “8-in-1” proof of concept for E-Axle systems for EVs, which controls eight functions with ...

Modifying Treatment for AADC Deficiency in the United States SOLANA BEACH, CA / ACCESSWIRE / November 13, 2024 / ...

Engineering and design software provider PTC (NASDAQ:PTC) met Wall Street’s revenue expectations in Q3 CY2024, with sales up 14.6% year on year to $626.5 million. On the other hand, next quarter’s ...